Opexa Pharmaceuticals, Inc. Reports First Quarter 2008 Financial Results and Updates on Tovaxin(R) Phase IIb Study

Published: May 14, 2008

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company involved in the development and commercialization of cell therapies, today reported financial results for the quarter ended March 31, 2008 and provided an update on its progress.

Back to news